GLOW
GLOW blend · GHK-Cu/BPC-157/TB-500
GLOW is a research blend combining three peptides — GHK-Cu, BPC-157 and TB-500 — in a 70 mg vial. Each component is documented in vitro for tissue-repair and dermatological signalling pathways. Reagent intended exclusively for laboratory research — not intended for human consumption.
Key facts
- Composition
- GHK-Cu 50 + BPC-157 10 + TB-500 10 mg
- Type
- 3-peptide blend
- Form
- Lyophilised (powder)
- Status
- Research Use Only
Documented research areas
Study library
All results on PubMedInjectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, et al. · The American journal of sports medicine · 2026
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, et al. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, et al. · Sports medicine (Auckland, N.Z.) · 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
Tewari K, et al. · The American journal of sports medicine · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Mavrych V, et al. · Frontiers in aging · 2026
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Luansritisakul C, et al. · Current pain and headache reports · 2026
Results retrieved live from PubMed (NCBI). Research literature only — no medical advice.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease